Badania
Edukacja
Rozwiązania
PL
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Zaloguj się
Translational Radiobiology,
Department of Radiation Oncology,
Uniklinikum Erlangen,
Translational Radiobiology, Department of Radiation Oncology, Uniklinikum Erlangen
Anna-Jasmina Donaubauer has not added Biography.
If you are Anna-Jasmina Donaubauer and would like to personalize this page please email our Author Liaison for assistance.
One-Tube Multicolor Flow Cytometry Assay (OTMA) for Comprehensive Immunophenotyping of Peripheral Blood.
Methods in molecular biology (Clifton, N.J.) , 2019 | Pubmed ID: 30539471
Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay.
Methods in enzymology , 2020 | Pubmed ID: 32000906
Low Dose Radiation Therapy, Particularly with 0.5 Gy, Improves Pain in Degenerative Joint Disease of the Fingers: Results of a Retrospective Analysis.
International journal of molecular sciences Aug, 2020 | Pubmed ID: 32824064
The Influence of Radiation on Bone and Bone Cells-Differential Effects on Osteoclasts and Osteoblasts.
International journal of molecular sciences Sep, 2020 | Pubmed ID: 32887421
Low- vs. high-dose radiotherapy in Graves' ophthalmopathy: a retrospective comparison of long-term results.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Oct, 2021 | Pubmed ID: 33860819
Chromosome Aberrations in Lymphocytes of Patients Undergoing Radon Spa Therapy: An Explorative mFISH Study.
International journal of environmental research and public health Oct, 2021 | Pubmed ID: 34682498
Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial.
Frontiers in immunology , 2021 | Pubmed ID: 34712229
Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients.
Frontiers in immunology , 2021 | Pubmed ID: 35046940
Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer.
Journal for immunotherapy of cancer Jan, 2022 | Pubmed ID: 35078923
Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial.
Frontiers in immunology , 2022 | Pubmed ID: 35197987
Anti-inflammatory effects of an autologous gold-based serum therapy in osteoarthritis patients.
Scientific reports Mar, 2022 | Pubmed ID: 35241691
Modulation of Differentiation and Bone Resorbing Activity of Human (Pre-) Osteoclasts After X-Ray Exposure.
Frontiers in immunology , 2022 | Pubmed ID: 35603191
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Dec, 2023 | Pubmed ID: 36602569
Prospective Evaluation of CD45RA+/CCR7- Effector Memory T (T) Cell Subsets in Patients with Primary and Secondary Brain Tumors during Radiotherapy of the Brain within the Scope of the Prospective Glio-CMV-01 Clinical Trial.
Cells Feb, 2023 | Pubmed ID: 36831183
Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial.
Neoplasia (New York, N.Y.) Mar, 2024 | Pubmed ID: 38232493
Osteo-immunological impact of radon spa treatment: due to radon or spa alone? Results from the prospective, thermal bath placebo-controlled RAD-ON02 trial.
Frontiers in immunology , 2023 | Pubmed ID: 38292488
Effects of serial radon spa therapy on pain and peripheral immune status in patients suffering from musculoskeletal disorders- results from a prospective, randomized, placebo-controlled trial.
Frontiers in immunology , 2024 | Pubmed ID: 38380316
Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients' peripheral blood.
Frontiers in oncology , 2024 | Pubmed ID: 39346733
Flow cytometry-based monitoring of myeloid-derived suppressor cells in the peripheral blood of patients with solid tumors.
Methods in cell biology , 2025 | Pubmed ID: 39824553
Friedrich-Alexander-Universität Erlangen-Nürnberg
Comprehensive Cancer Center Erlangen-EMN
Bayerischerisches Zentrum für Krebsforschung
Anna-Jasmina Donaubauer1,2,3,
Anna Schäfer1,
Simon Hundsdorfer1,
Rainer Fietkau2,4,
Udo S. Gaipl1,2,
Tina Jost1,2
1Translational Radiobiology, Department of Radiation Oncology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg,
2, Comprehensive Cancer Center Erlangen-EMN,
3, Bayerischerisches Zentrum für Krebsforschung,
4Department of Radiation Oncology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg
Prywatność
Warunki Korzystania
Zasady
Skontaktuj Się z Nami
Poleć Bibliotece
BIULETYNY JoVE
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archiwum
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Business
JoVE Quiz
JoVE Playlist
Autorzy
Bibliotekarze
Dostęp
O JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone